Who Paid My Doc
Research studies in the Open Payments record
139,921 studies have research funding reported against them. Being named on a study as a principal investigator is reported separately from being paid.
Studies
50 of 139,921- Lvm-MD-14 (Prea/Pmr/Phase 3/Double-Blind) No ClinicalTrials.gov identifier reported
- Lvm-MD-14 (Prea/Pmr/Phase 3/Double-Blind) No ClinicalTrials.gov identifier reported
- Lvm-MD-14 Preapmrphase 3Double-Blind No ClinicalTrials.gov identifier reported
- Lvos-1-19094 No ClinicalTrials.gov identifier reported
- LVRC IDE Crossover Study NCT00004451
- LVRC IDE Crossover Study NCT02059057
- Lx1606.1-111-Hep No ClinicalTrials.gov identifier reported
- Lx1606.1-207-Btc No ClinicalTrials.gov identifier reported
- Lx1606.207 BTC No ClinicalTrials.gov identifier reported
- Lx1606.303 No ClinicalTrials.gov identifier reported
- Lx2761.102 No ClinicalTrials.gov identifier reported
- Lx4211.1-121-Ren No ClinicalTrials.gov identifier reported
- Lx9211 No ClinicalTrials.gov identifier reported
- Lx9211 No ClinicalTrials.gov identifier reported
- Lx9211 No ClinicalTrials.gov identifier reported
- Lx9211.1-104-Qtc No ClinicalTrials.gov identifier reported
- Lx9211.1-201-Dpn No ClinicalTrials.gov identifier reported
- Lx9211.1-204-Dpn No ClinicalTrials.gov identifier reported
- Lx9211.1-204-Dpn No ClinicalTrials.gov identifier reported
- LX9211.1-204-DPN-A Phase 2b, Dose-ranging, Randomized, Double-blind, Placebo-controlled, Parallel-Group, Multicenter Study with an Open0label Extension in Patients with Diabetic Peripheral Neurophathic Pain. No ClinicalTrials.gov identifier reported
- Ly3527727 Study No ClinicalTrials.gov identifier reported
- LymeDetect 2022 Clinical Study No ClinicalTrials.gov identifier reported
- LymeDetect 2022 Clinical Study No ClinicalTrials.gov identifier reported
- LymeDetect Clinical Study No ClinicalTrials.gov identifier reported
- LymeDetect (Project 500685) Clinical Study No ClinicalTrials.gov identifier reported
- Lyme Disease Study No ClinicalTrials.gov identifier reported
- Lyme IgG XS Clinical Study No ClinicalTrials.gov identifier reported
- Lyme IgM XS Clinical Study No ClinicalTrials.gov identifier reported
- Lyme Total Antibody XS Clinical Study No ClinicalTrials.gov identifier reported
- Lymphodepletion +ACT Without Dendritic Cell Immunization NCT00338377
- Lymphodepletion +ACT Without Dendritic Cell Immunization NCT00338377
- Lymphodepletion +Act Without Dendritic Cell Immunization No ClinicalTrials.gov identifier reported
- Lymphoma genome Project No ClinicalTrials.gov identifier reported
- Lyons, Steven, 1751, CLU2018-13CH: mymobility Phase 0 Clinical Study No ClinicalTrials.gov identifier reported
- Lyophozation Urine Site Collection No ClinicalTrials.gov identifier reported
- Lyra Direct SARS-CoV-2 and Lyra SARS-CoV-2 Validation Study No ClinicalTrials.gov identifier reported
- Lyra Direct SARS-CoV-2 plus Lyra SARS-CoV-2 Validation Study No ClinicalTrials.gov identifier reported
- Lyricleumc No ClinicalTrials.gov identifier reported
- Lyshchik_Contrast Enhanced Ultrasound Evaluation of Focal Liver Lesions in Patients With Cirrhosis Or Other Risk Factors for Developing HCC No ClinicalTrials.gov identifier reported
- Lysophosphatidic Acid Receptor 1 Inhibition: A Potential Treatment Target for Pulmonary Fibrosis No ClinicalTrials.gov identifier reported
- Lysophospholipid Metabolites in Inflammatory Arthritis No ClinicalTrials.gov identifier reported
- Lysophospholipid Metabolites in Inflammatory Arthritis Prospective No ClinicalTrials.gov identifier reported
- Lysosomal Acid Lipase (LAL) Deficiency Registry (ALX-LALD-501) NCT01633489
- Lysosomal Acid Lipase LAL Deficiency Registry ALX-LALD-501 NCT01633489
- M06-873 NCT00481091
- M10-166 NCT00788684
- M10-855 NCT01655680
- M10-870 NCT02632175
- M10-883 NCT01064856
- M10-897 NCT01657799